- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04415580
Vestibular Rehabilitation and Severe Traumatic Brain Injury
June 21, 2021 updated by: Marco Tramontano, I.R.C.C.S. Fondazione Santa Lucia
Effects of Vestibular Rehabilitation in Patients With Severe Traumatic Brain Injury: a Randomized Controlled Trial
Severe brain injury (sTBI) is one of the most common causes of long-term disability and is considered the most frequent cause of mortality and serious disability in young adults in industrialized countries.
It is defined as an alteration of brain function with loss of consciousness in the acute phase for at least 24 hours (Glasgow Coma Scale (GCS) <8) and it can induce a wide range of deficit, including cognitive-behavioural, motors, psychics, language, vision, coordination and balance impairments.
Chronic vestibular symptoms such as dizziness and balance deficits (both static and dynamic postural instability) are present in patients with brain injury.
These aspects can cause functions limitation and psychological distress, negatively impacting negatively on subjects' quality of life and social reintegration and are considered unfavourable prognostic factors of the recovery process.
The literature supports the use of vestibular rehabilitation techniques in patients with mild and moderate brain injury, however, to date, no studies investigated the effect of vestibular rehabilitation in sTBI patients.
The main aim of this randomized controlled trail is to verify the effect of a personalized vestibular training on balance and gait disorders in sTBI patients.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rm
-
Roma, Rm, Italy, 00179
- Santa Lucia Foundation I.R.C.C.S.
-
Roma, Rm, Italy, 00179
- Marco Tramontano
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 65 years (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age between 15 and 65 years;
- Glasgow coma scale (GCS) score ≤ 8 (used to objectively describe the severity of impaired consciousness at the time of injury)
- Level of cognitive functioning (LCF) ≥7;
- Ability to understand verbal commands and the informed consent.
- Presence of static and dynamic balance impairments.
- Functional Ambulation Classification (FAC) ≥ 3
Exclusion Criteria:
- Glasgow coma scale (GCS) score >8
- Level of cognitive functioning (LCF) <7
- Inability to understand verbal commands
- Absence of static and dynamic balance impairments.
- Functional Ambulation Classification (FAC) < 3
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Vestibular Rehabilitation Group
|
VR consisted of two types of exercises, i.e., those for gaze stability and those for postural stability
When patients made the mistake of changing direction, the physiotherapist help them to keep the right position using verbal cues (e.g., you are turning left or right). |
ACTIVE_COMPARATOR: Conventional rehabilitation Group
|
muscles stretching, active and assisted limbs mobilization, four limbs coordination exercises, balance training on instable platform and gait training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dynamic Gait Index Scoring Form (DGI)
Time Frame: Baseline to 8 weeks after the end training
|
Change of Dynamic Gait Index Scoring Form (DGI) from baseline at 4 weeks of training, at 4 weeks after the end of the training and after 8 weeks after the end of the training.
DGI values ranging from 0 to 24, where 0 means the worse outcome and 24 the best one.
|
Baseline to 8 weeks after the end training
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Berg Balance Scale (BBS)
Time Frame: Baseline to 8 weeks after the end training
|
Change of Berg Balance Scale (BBS) from baseline at 4 weeks of training, at 4 weeks after the end of the training and after 8 weeks after the end of the training.
BBS values ranging from 0 to 56, where 0 means the worse outcome and 56 the best one
|
Baseline to 8 weeks after the end training
|
Community Balance & Mobility Scale (CB&M)
Time Frame: Baseline to 8 weeks after the end training
|
Change of Community Balance and Mobility Scale (CB&M) from baseline at 4 weeks of training, at 4 weeks after the end of the training and after 8 weeks after the end of the training.
CB&M values ranging from 0 to 96, where 0 means the worse outcome and 96 the best one.
|
Baseline to 8 weeks after the end training
|
Activities-specific Balance Confidence scale (ABC)
Time Frame: Baseline to 8 weeks after the end training
|
Change of Activities-specific Balance Confidence scale (ABC) from baseline at 4 weeks of training, at 4 weeks after the end of the training and after 8 weeks after the end of the training.
ABC values ranging from 0% to 100%, where 0% means the worse outcome and 100% the best one.
|
Baseline to 8 weeks after the end training
|
Community Integration Questionnaire (CIQ)
Time Frame: Baseline to 8 weeks after the end training
|
Change of Community Integration Questionnaire (CIQ) from baseline at 4 weeks of training, at 4 weeks after the end of the training and after 8 weeks after the end of the training.
CIQ values ranging from 0 to 29, where 0means the worse outcome and 29 the best one.
|
Baseline to 8 weeks after the end training
|
Dizziness Handicap Inventory (DHI)
Time Frame: Baseline to 8 weeks after the end training
|
Dizziness Handicap Inventory (DHI) from baseline at 4 weeks of training, at 4 weeks after the end of the training and after 8 weeks after the end of the training.
DHI values ranging from 0 to 100, where 100 means the worse outcome and 0 the best one.
|
Baseline to 8 weeks after the end training
|
Instrumental Assessment
Time Frame: Baseline to 8 weeks after the end training
|
Postural and gait functional assessment performed using inertial motion capture systems (Opal, APDM Inc., Portland, Oregon, USA, portable devices controlling 6 inertial/magnetic measurement units providing 3D orientation and kinematic).
The assessments were performed at the baseline, 4 weeks of training, at 4 weeks after the end of the training and after 8 weeks after the end of the training
|
Baseline to 8 weeks after the end training
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 1, 2020
Primary Completion (ACTUAL)
February 26, 2021
Study Completion (ACTUAL)
June 21, 2021
Study Registration Dates
First Submitted
May 31, 2020
First Submitted That Met QC Criteria
June 2, 2020
First Posted (ACTUAL)
June 4, 2020
Study Record Updates
Last Update Posted (ACTUAL)
June 22, 2021
Last Update Submitted That Met QC Criteria
June 21, 2021
Last Verified
June 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FSLCE/PROG.700
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gait Disorders, Neurologic
-
University of ZurichRecruitingGait, Stumbling | Gait, PerturbationSwitzerland
-
University of ChicagoRecruiting
-
NUMEN FoundationUniversidad Europea de MadridNot yet recruiting
-
Rehaklinik Zihlschlacht AGRecruiting
-
Kirsehir Ahi Evran UniversitesiNot yet recruiting
-
Samsung Medical CenterCompletedHealthy | Gait, UnsteadyKorea, Republic of
-
Swiss Federal Institute of TechnologyBalgrist University HospitalCompletedGait Disorder, SensorimotorSwitzerland
-
Umm Al-Qura UniversityRecruiting
-
University of PittsburghNational Institute on Aging (NIA)Withdrawn
-
Istituto Ortopedico GaleazziCompleted
Clinical Trials on Vestibular Rehabilitation (VR)
-
University of JordanCompletedVestibular DizzinessJordan
-
Bergen University CollegeUniversity of Bergen; Duke University; Haukeland University Hospital; University... and other collaboratorsActive, not recruitingVertigo | Dizziness | Vestibular NeuritisNorway
-
Oslo University HospitalOslo University CollegeCompletedDizziness | Traumatic Brain Injury | Brain Concussion | Head InjuryNorway
-
Clarkson UniversityNot yet recruiting
-
Clarkson UniversityTemple UniversityRecruitingVirtual Reality | Vestibular Training | Balance AssessmentUnited States
-
Oregon Health and Science UniversityPortland VA Medical CenterCompletedBrain InjuryUnited States
-
National Cheng Kung UniversityRecruiting
-
Maria Jesus Casuso-HolgadoNot yet recruitingQuality of Life | Multiple Sclerosis | Fatigue | Dizziness | Vestibular Disease | Usability | Balance Disorders | CybersicknessSpain
-
Boston Children's HospitalCompletedVestibular DiseasesUnited States